Using comprehensive bioinformatics analyses, we identified the expression of UBA1, a gene frequently gained in cancer, as being associated with low levels of intratumoral CD8+ T cells, ICB resistance, and poor survival in ICB-treated cohorts. Here, CD8A is linked to cancer.